Quantcast
Home > Quotes > AKER

Akers Biosciences Inc Common Stock (AKER) Quote & Summary Data

AKER 
$0.2499
*  
0.0003
0.12%
Get AKER Alerts
*Delayed - data as of Sep. 21, 2018  -  Find a broker to begin trading AKER now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 0.258 / $ 0.243
Share Volume
1,407,399
50 Day Avg. Daily Volume
2,232,645
Previous Close
$ 0.2496
52 Week High / Low
$ 1.82 / $ 0.122
Market Cap
23,517,162
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.59

Intraday Chart

Shares Traded

Share Volume:
1,407,399
50 Day Avg. Daily Volume:
2,232,645

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.41

Trading Range

The current last sale of $0.2499 is 104.84% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.258 $ 1.82
 Low: $ 0.243 $ 0.122

Company Description (as filed with the SEC)

Akers Biosciences, Inc. ("Akers," "we" or the "Company") develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner. Akers believes it has advanced the science of diagnostics through the development of several innovative proprietary platform technologies that provide product development flexibility. All of Akers' rapid, single-use tests are performed in vitro (outside the body) and are designed to enhance patient well-being and reduce total outcome costs of healthcare. The Company's current product offerings and pipeline products focus on delivering diagnostic assistance in a wide variety of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory disease and infectious disease detection, as well as for on and off-the-job alcohol safety initiatives.  ... More ...  

Nasdaq Official Price

Open Price:
$ 0.25
Open Date:
Sep. 21, 2018
Close Price:
$ 0.2496
Close Date:
Sep. 21, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info